About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
LCTX
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Lineage Cell Therapeutics GAAP EPS of -$0.03 beats by $0.01, revenue of $2.39M beats by $0.38M
- Lineage Cell Therapeutics GAAP EPS of -$0.15 in-line, revenue of $14.7M misses by $0.63M
- Lineage Cell Therapeutics Q4 2022 Earnings Preview
- Lineage, Eterna team up to develop cell lines for neurological conditions
- Lineage Cell Therapeutics GAAP EPS of -$0.04, revenue of $3M
- Lineage Cell Therapeutics Q3 2022 Earnings Preview
- Lineage receives U.S. notice of allowance for two patents for spinal cord injury treatment
- Lineage Cell Therapeutics GAAP EPS of -$0.04, revenue of $4.6M
- Lineage Cell Therapeutics Q2 2022 Earnings Preview
- Lineage expands collaboration with Advanced Biomatrix for drug delivery technology
- Lineage Cell Therapeutics GAAP EPS of -$0.04 misses by $0.02, revenue of $5.24M misses by $3.66M
- Lineage Cell Therapeutics Q1 2022 Earnings Preview
- Lineage Cell buoyed by phase 1/2a results for macular degeneration therapy
- Lineage stock rises after announcing cell therapy program to treat vision loss
- Lineage Cell Therapeutics GAAP EPS of -$0.17 misses by $0.12, revenue of $1.2M beats by $0.56M
- Lineage jumps 11% on collaboration with Genentech in ocular disorders
- ICE Biotech index rejig: AUPH, AVXL among added; AMRS, GH among deleted
- Lineage Cell Therapeutics EPS in-line, beats on revenue
- Lineage Cell Therapeutics Q3 2021 Earnings Preview
- Lineage Cell OpRegen interim data indicates improvement trend in visual acuity for AMD
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 | 1.400 | 1.390 |
1.415
|
1.360
|
354.08K | -1.41% | ||||
| Mar 9 | 1.420 | 1.350 |
1.430
|
1.330
|
445.56K | 8.40% | ||||
| Mar 8 | 1.310 | 1.280 |
1.400
|
1.280
|
596.99K | 2.34% | ||||
| Mar 7 | 1.280 | 1.300 |
1.310
|
1.255
|
688.86K | 1.59% | ||||
| Mar 4 | 1.260 | 1.310 |
1.330
|
1.260
|
571.32K | -3.82% | ||||
| Mar 3 | 1.310 | 1.360 |
1.360
|
1.310
|
288.83K | -2.96% | ||||
| Mar 2 | 1.350 | 1.370 |
1.390
|
1.340
|
231.87K | -1.46% | ||||
| Mar 1 | 1.370 | 1.400 |
1.432
|
1.340
|
364.44K | -2.84% | ||||
| Feb 28 | 1.410 | 1.380 |
1.430
|
1.370
|
592.27K | -2.08% | ||||
| Feb 25 | 1.440 | 1.420 |
1.440
|
1.365
|
400.89K | 0.70% | ||||
| Feb 24 | 1.430 | 1.270 |
1.430
|
1.260
|
979.24K | 6.72% | ||||
| Feb 23 | 1.340 | 1.410 |
1.421
|
1.340
|
670.57K | -4.96% | ||||
| Feb 22 | 1.410 | 1.440 |
1.455
|
1.400
|
613.32K | -3.42% | ||||
| Feb 18 | 1.460 | 1.490 |
1.510
|
1.440
|
458.22K | -3.31% | ||||
| Feb 17 | 1.510 | 1.550 |
1.570
|
1.510
|
470.31K | -3.82% | ||||
| Feb 16 | 1.570 | 1.540 |
1.570
|
1.515
|
288.10K | 0% | ||||
| Feb 15 | 1.570 | 1.520 |
1.570
|
1.500
|
505.53K | 4.67% | ||||
| Feb 14 | 1.500 | 1.500 |
1.520
|
1.460
|
485.54K | 0% | ||||
| Feb 11 | 1.500 | 1.500 |
1.555
|
1.490
|
571.04K | -0.66% | ||||